“…Plasma samples screened in this study consisted of 6096 individual plasma samples collected from one Chinese blood product manufacturer between October 2012 and September 2013 (October 2012, 893 samples; November 2012, 90; December 2012, 714; January 2013, 719; February 2013, 711; March 2013, 630; April 2013, 90; May 2013, 630; June 2013, 449; July 2013, 450; August 2013, 360; September 2013, 360), 241 plasma pools, and 326 batches of blood products (including 65 batches of albumin, 197 batches of intravenous immunoglobulin [IVIG], 47 batches of anti‐hemophilic Factor VIII [FVIII], 12 batches of fibrinogen, and five batches of prothrombin complex concentrate [PCC]) that had been collected in our laboratory during 2010 to 2012. All the samples tested negative for routine pathogens according to standards established by the Chinese Ministry of Health (routine pathogens were tested by the blood product manufacturers) …”